Brief: Orexo Announces Positive Data For Powder-Based Intranasal Vaccine
10/04/2025 09:33
April 10 (Reuters) - Orexo AB ORX.ST: OREXO ANNOUNCES POSITIVE DATA FOR POWDER-BASED INTRANASAL VACCINE FORMULATED WITH THE AMORPHOX TECHNOLOGY Source text: ID:nPn534qZga Further company coverage: ORX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))